Response to Immunotherapy Linked with Improved Liver Function in Advanced Hepatocellular Carcinoma (HCC)
Response to Immunotherapy Linked with Improved Liver Function in Advanced Hepatocellular Carcinoma (HCC) Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, poses significant treatment challenges, especially in its advanced stages. Traditional treatment options such as surgery, chemotherapy, and targeted therapy often fall short, leaving patients with limited hope for improved outcomes. However, … Read more